{"id":"W2118825330","doi":"10.1056/nejmoa1206797","title":"Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":2035,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"Genentech; Servier; Amarin Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; F. Hoffmann-La Roche; Kowa Company; Sanofi; Esperion Therapeutics; GlaxoSmithKline; Amgen; Pfizer; Anthera","keywords":"Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006342912869336956,"score_gpt":0.2221860302295541,"score_spread":0.2158431173602171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}